首页> 外国专利> TREATMENT OF OROPHARYNGEAL DYSPHAGIA

TREATMENT OF OROPHARYNGEAL DYSPHAGIA

机译:口咽性咽炎的治疗

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention relates to perorally introduced product in form of viscosified drink, which is capable of stimulating swallowing reflex in an individual, containing thickening agent and at least one vanilloid receptor (VR-1) agonist, selected from group consisting of: capsiate, dihydrocapsaicine, nordihydrocapsaicine dihydrocapsiate, nordihydrocapsiate, homocapsaicine, homodihydro-capsaicine, vanillyl amyl n-nonanoic acid (VNA), anandomide, resiniferatoxin and olvanil. Product can also be liquid or with modified structure. Invention also relates to product application for prevention or treatment of oropharyngeal dysphagia in an individual.;EFFECT: invention ensures increased safety of swallowing, improvement of swallowing response time and reduction of side effects, associated with intake of vanilloid receptor antagonists, such as burning sensation, dizziness, nausea, vomiting, and shortness of breath.;21 cl
机译:口服增稠饮料产品和方法技术领域本发明涉及以增粘饮料形式经口引入的产品,其能够刺激个体的吞咽反射,其包含增稠剂和至少一种类香草素受体(VR-1)激动剂,其选自:由以下组成的组:辣椒素,二氢辣椒素,去甲二氢辣椒素二氢辣椒素,去甲二氢辣椒素,高辣椒素,高二氢辣椒素,香草基戊基正壬酸(VNA),阿诺定,树脂树脂毒素和奥瓦尼。产品也可以是液体或结构改变。本发明还涉及用于预防或治疗个体口咽吞咽困难的产品应用。效果:本发明确保吞咽的安全性提高,吞咽反应时间的改善和副作用的减少,与摄入类香草素受体拮抗剂有关,例如烧灼感,头晕,恶心,呕吐和呼吸急促; 21 cl

著录项

  • 公开/公告号RU2481829C2

    专利类型

  • 公开/公告日2013-05-20

    原文格式PDF

  • 申请/专利权人 NESTEK S.A.;

    申请/专利号RU20100125285

  • 发明设计人 MILLER KEVIN BERK (US);

    申请日2008-10-07

  • 分类号A61K31/164;A61K31/165;A61K31/357;A61K45/06;A61P1;A23L1/30;

  • 国家 RU

  • 入库时间 2022-08-21 16:23:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号